PDS5B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.411000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.496800E-01
Normal-vs-Stage2
2.016200E-01
Normal-vs-Stage3
2.269800E-02
Normal-vs-Stage4
6.068800E-01
Stage1-vs-Stage2
2.847800E-01
Stage1-vs-Stage3
1.427680E-02
Stage1-vs-Stage4
9.451000E-01
Stage2-vs-Stage3
4.994200E-02
Stage2-vs-Stage4
4.178000E-01
Stage3-vs-Stage4
9.075100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.304800E-01
Normal-vs-AfricanAmerican
5.329400E-01
Normal-vs-Asian
7.972400E-02
Caucasian-vs-AfricanAmerican
6.143800E-01
Caucasian-vs-Asian
2.698200E-01
AfricanAmerican-vs-Asian
2.499000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.744800E-01
Normal-vs-Female
2.230400E-01
Male-vs-Female
7.460400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.755800E-01
Normal-vs-Age(41-60Yrs)
4.975400E-01
Normal-vs-Age(61-80Yrs)
1.922210E-01
Normal-vs-Age(81-100Yrs)
3.283900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.669800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.103000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.119800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.019500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.022100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.876200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.735600E-02
Normal-vs-Daily Drinker
3.179900E-02
Normal-vs-Weekly Drinker
5.136300E-02
Normal-vs-Occasional Drinker
7.243200E-01
Normal-vs-Social Drinker
6.245600E-01
Non Drinker-vs-Daily Drinker
6.194200E-01
Non Drinker-vs-Weekly Drinker
9.553600E-01
Non Drinker-vs-Occasional Drinker
1.470270E-02
Non Drinker-vs-Social Drinker
7.471600E-02
Daily Drinker-vs-Weekly Drinker
6.951600E-01
Daily Drinker-vs-Occasional Drinker
7.498100E-03
Daily Drinker-vs-Social Drinker
7.111600E-02
Weekly Drinker-vs-Occasional Drinker
3.824000E-02
Weekly Drinker-vs-Social Drinker
1.279220E-01
Occasional Drinker-vs-Social Drinker
7.326200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.745600E-02
Normal-vs-Grade 2
1.807780E-02
Normal-vs-Grade 3
1.497990E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.334800E-01
Grade 1-vs-Grade 3
9.152400E-01
Grade 1-vs-Grade 4
9.745600E-02
Grade 2-vs-Grade 3
8.752000E-01
Grade 2-vs-Grade 4
1.807780E-02
Grade 3-vs-Grade 4
1.497990E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.461160E-01
Normal-vs-NonDiabetic
1.918970E-01
Diabetic-vs-NonDiabetic
5.232000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.195600E-02
Normal-vs-NoPancreatitis
2.112200E-01
Pancreatitis-vs-NoPancreatitis
4.749800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.588000E-01
Normal-vs-N1
2.000200E-01
N0-vs-N1
5.521000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.921200E-01
Normal-vs-TP53-NonMutant
5.636200E-01
TP53-Mutant-vs-TP53-NonMutant
6.542200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
